Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1

Interventions

Capecitabine 5Bevacizumab 5Radiotherapy 3Oxaliplatin 3olaparib 2durvalumab 2darolutamide 2dalpiciclib 2atezolizumab 2apatinib 2anlotinib 2Surgical Procedures, Operative 2Standard of Care 2Radiosurgery 2Leucovorin 2Laparoscopy 2Immunotherapy 2Fluorouracil 2Drug Therapy 2trametinib 1toripalimab 1tislelizumab 1spartalizumab 1pyrotinib 1pomalidomide 1palbociclib 1nilotinib 1ledipasvir, sofosbuvir drug combination 1ledipasvir 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Prebiotics × 90 days × Clear all
NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Instituto Jalisciense de Cancerologia

Phase NA Enrolling by invitation
80 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡